Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 Nov 2025 |
On P&L |
The Company releases the press release related to the first nine months of 2025 financial results
|
Download |
|
06 Nov 2025 |
On P&L |
The Company releases the first nine months of 2025 financial results presentation
|
Download |
|
21 Oct 2025 |
On business and financial situation |
The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
02 Oct 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the third quarter of 2025
|
Download |
|
04 Jul 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the second quarter of 2025
|
Download |
|
03 Jul 2025 |
Other relevant information |
The Company informs about the dividends payment.
|
Download |
|
18 Jun 2025 |
Announcement of general shareholders’ meeting |
The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors.
|
Download |
|
08 May 2025 |
On business and financial situation |
The Company releases the press release related to the first three months of 2025 financial results
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Jul 2019 |
R&D: new licenses, patents and registered trademarks |
ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria® for the treatment of schizophrenia.
|
Download |
|
02 Jul 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the second quarter of 2019
|
Download |
|
26 Jun 2019 |
Información sobre dividendos |
The Company informs about the dividends payment
|
Download |
|
12 Jun 2019 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
08 May 2019 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI releases the information related to its 2019 General Shareholders Meeting
|
Download |
Pages
